Related Experiment Videos
Summary
Four infants experienced silent, complete obstructed apnea, primarily central sleep apnea with hypoventilation. Theophylline and atropine showed potential in managing these severe infant breathing events.
Area of Science:
- Pediatrics
- Sleep Medicine
- Neonatology
Background:
- Episodic silent complete obstructed apnea is a rare but serious condition in infants.
- Central sleep apnea and hypoventilation can present without obvious obstructive events.
- Family history of sudden infant death syndrome (SIDS) or near-miss events may indicate a genetic predisposition.
Purpose of the Study:
- To describe the clinical presentation and outcomes of four infants with episodic silent complete obstructed apnea.
- To investigate the role of central sleep apnea and hypoventilation in these cases.
- To evaluate potential therapeutic interventions for this condition.
Main Methods:
- Case series describing four infants with detailed clinical histories.
- Polygraphic recordings (polysomnography) to assess sleep apnea.
- Review of treatment responses to theophylline and atropine.
Main Results:
- All four infants presented with central sleep apnea; three also had hypoventilation.
- No obstructive apnea was documented on polygraphic recordings.
- One infant experienced a fatal prolonged episode that initiated while awake.
- Theophylline controlled apnea in two infants; atropine was linked to resolution in a third.
Conclusions:
- Episodic silent complete obstructed apnea in infants is often characterized by central sleep apnea and hypoventilation.
- Early identification and intervention, potentially with medications like theophylline or atropine, may be crucial.
- Further research is needed to understand the pathophysiology and optimize management strategies.